Viewing Study NCT05664750


Ignite Creation Date: 2025-12-24 @ 4:49 PM
Ignite Modification Date: 2026-01-01 @ 8:22 AM
Study NCT ID: NCT05664750
Status: COMPLETED
Last Update Posted: 2024-03-08
First Post: 2022-12-07
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study to Compare the Efficacy and Safety of Passive Immunization With TNM002 Injection and Human Tetanus Immunoglobulin as Prophylaxis Against Tetanus
Sponsor: Zhuhai Trinomab Pharmaceutical Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module